Stock listing

NASDAQ:ATXS Astria Therapeutics Inc Stock

Follow Astria Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ATXS

$12.50 USD

Close on Jan 21, 2026 · No longer trades

Aug 20, 2021 to last close +64.9% · weekly closes, Aug 20, 2021 – Jan 21, 2026
Lowest – highest close
$2.46 – $16.69 USDSince Aug 20, 2021 · lowest Jun 16, 2022 · highest Mar 19, 2024

Delisted NASDAQ:ATXS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ATXS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Astria Therapeutics Inc on 6ix

Calls
2 calls with a replay · 2 with a transcript · latest Nov 13, 2023
Decks
12 decks · latest Oct 14, 2025

Where Astria Therapeutics Inc is listed

ListingExchangeCountryCurrency
NASDAQ:ATXS · This page · DelistedNASDAQUnited StatesUSD
NASDAQ:CATB · DelistedNASDAQUnited StatesUSD

Events

CallWhenStatus
Astria Therapeutics (ATXS) Q3 2023 Earnings CallMon, Nov 13, 2023 · 8:30 AM ETReplay
Astria Therapeutics (ATXS) Q3 2021 Earnings CallWed, Nov 10, 2021 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (October 2025)Merger or acquisition14 slidesOct 14, 2025
Merger or Acquisition (October 2025)Merger or acquisition11 slidesOct 14, 2025
Investor Presentation (January 2025)Investor deck38 slidesJan 13, 2025
Investor Presentation (October 2023)Investor deck28 slidesOct 11, 2023
Investor Presentation (January 2023)Investor deck19 slidesJan 5, 2023
Technical Presentation (December 2022)Technical30 slidesDec 15, 2022
Investor Presentation (September 2021)Investor deck21 slidesSep 8, 2021
Catabasis Pharmaceuticals — Investor Presentation (June 2021)Investor deck19 slidesJun 2, 2021
Catabasis Pharmaceuticals — Merger or Acquisition (January 2021)Merger or acquisition21 slidesJan 29, 2021
Catabasis Pharmaceuticals — Investor Presentation (December 2017)Investor deck35 slidesDec 11, 2017
All 12 decks
DeckKindSlidesDate
Catabasis Pharmaceuticals — Corporate Update (October 2017)Corporate update28 slidesOct 4, 2017
Catabasis Pharmaceuticals — Corporate Update (June 2017)Corporate update28 slidesJun 19, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Joseph Edelman
Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Immatics N.V. (Director · Since at least Mar 18, 2026); Solid Biosciences Inc. (Director · Since at least Mar 23, 2021); MeiraGTx Holdings plc (Director · Since at least Nov 23, 2020); LeonaBio, Inc. (Director · Since at least Sep 17, 2020); Adagio Medical Holdings, Inc (Director · Jan 22, 2025 – Jan 22, 2025 · Past); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); ARYA Sciences Acquisition Corp V (Director · Jul 12, 2021 – Jul 12, 2021 · Past); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past); Landos Biopharma Inc (Director · Feb 3, 2021 – Aug 27, 2021 · Past); Nautilus Biotechnology, Inc. (Director · Aug 6, 2020 – Jun 14, 2024 · Past); Cerevel Therapeutics Holdings Inc (Director · Jun 4, 2020 – Feb 20, 2024 · Past); Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – May 31, 2023 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Oct 5, 2018 · Past)
Director · Jan 28, 2021 – Feb 1, 2024 · Past
Kenneth Bate
Other companies: Madrigal Pharmaceuticals, Inc. (Director · Since at least Jul 22, 2016); Vanda Pharmaceuticals Inc. (Director · Dec 17, 2015 – Jun 15, 2017 · Past); Epizyme Inc (Director · Dec 10, 2014 – Aug 12, 2022 · Past); BioMarin Pharmaceutical Inc. (Director · Sep 22, 2010 – Jun 10, 2015 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jan 19, 2023 · Past); Coley Pharmaceutical Group Inc (Director · Jun 21, 2006 – Jan 4, 2008 · Past); Cubist Pharmaceuticals Inc (Director · Jun 8, 2006 – Jan 21, 2015 · Past); Nitromed Inc (President & CEO, Director · Mar 20, 2006 – Apr 24, 2009 · Past)
Director · Since at least Jun 24, 2015
Nicholas Galakatos
Other companies: Tourmaline Bio Inc. (Director · May 6, 2021 – May 6, 2021 · Past); Praxis Precision Medicines, Inc. (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); IVERIC bio Inc (Director · Sep 25, 2013 – Jan 11, 2016 · Past); NanoString Technologies Inc (Director · Jun 25, 2013 – Mar 25, 2019 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 27, 2014 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jun 1, 2011 · Past); Affymax Inc (Director · Dec 14, 2006 – May 28, 2009 · Past)
Director · Jun 24, 2015 – Aug 3, 2016 · Past
Jean George
Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 22, 2020 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past)
Director · Jun 24, 2015 – Jun 7, 2018 · Past
Sunil Agarwal
Other companies: Arvinas, Inc. (Director · Since at least Jun 15, 2023); Sana Biotechnology, Inc. (EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past); Juno Therapeutics Inc (President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past); MyoKardia Inc (Director · Mar 4, 2016 – Nov 17, 2020 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past)
Director · Since at least Apr 5, 2024
Anthony Gregg Lapointe
Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Oct 31, 2017); Soligenix, Inc. (Director · Since at least Mar 10, 2009); Raptor Pharmaceutical Corp (Director · Jan 1, 2015 – Oct 24, 2016 · Past); Questcor Pharmaceuticals Inc (Director · Oct 9, 2009 – Jan 1, 2010 · Past); SciClone Pharmaceuticals Inc (Director · Mar 30, 2009 – Oct 13, 2017 · Past)
Director · Since at least Jan 3, 2019
Jonathan Violin
Other companies: Cyclerion Therapeutics, Inc. (Chief Executive Officer · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Dianthus Therapeutics, Inc. (Director · Since at least Sep 11, 2023); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Oct 27, 2020 – Feb 2, 2023 · Past); Trevena, Inc. (SVP-Scientific Affairs & IR · Jan 29, 2018 – Feb 28, 2018 · Past)
Director · Since at least Jan 28, 2021
Michael Jay Ross
Other companies: Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Jun 15, 2022 · Past); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Sep 27, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Deciphera Pharmaceuticals LLC (Director · Sep 27, 2017 – Jun 11, 2019 · Past); IVERIC bio Inc (Director · Sep 24, 2013 – May 23, 2018 · Past)
Director · Jun 24, 2015 – Jun 7, 2018 · Past
Burt A Adelman
Other companies: Verve Therapeutics Inc (Director · Since at least Jun 16, 2021); Dyax Corp (CMO & EVP, R&D · Aug 9, 2012 – Jan 22, 2016 · Past); Biogen Inc. (EVP, Portfolio Strategy · Jan 3, 2006 – Dec 31, 2007 · Past)
Director · Apr 5, 2016 – Jun 11, 2020 · Past
Fred Callori
Other companies: LeonaBio, Inc. (Director · Since at least May 5, 2026); Landos Biopharma Inc (Director · Aug 27, 2021 – May 23, 2024 · Past)
Director · Since at least Jan 28, 2021
All 26 people
PersonSeat
Hugh M Cole
Other companies: Jounce Therapeutics Inc (Chief Operating Officer · Dec 20, 2017 – Jan 9, 2023 · Past); Ariad Pharmaceuticals Inc (SVP, Chief Business Officer · Apr 29, 2016 – Feb 16, 2017 · Past)
Director · Since at least Jul 26, 2019
Michael D Kishbauch
Other companies: Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past); Achillion Pharmaceuticals Inc (Director · Jan 25, 2016 – Jan 28, 2020 · Past)
Director · Since at least Apr 5, 2016
Benjamin Harshbarger
Other companies: Xilio Therapeutics, Inc. (Chief Legal Officer · Since Jun 29, 2026 · Appointed, no departure found)
Chief Legal Officer · Since at least Jun 2, 2023
Christopher Morabito
Other companies: Fulcrum Therapeutics, Inc. (Chief Medical Officer · May 10, 2021 – Jan 19, 2022 · Past)
Chief Medical Officer · Since at least Jul 14, 2022
Jill Milne
Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jan 23, 2026)
CEO and President, Director · Since at least Jun 24, 2015
Joanne M. Donovan
Other companies: Edgewise Therapeutics, Inc. (Chief Medical Officer · Since at least Apr 26, 2021)
CMO; SVP Clinical Development · Jun 24, 2015 – Feb 12, 2020 · Past
Joanne T Beck
Other companies: Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past)
Director · Since at least Feb 13, 2019
Rick Modi
Other companies: AveXis Inc (Chief Business Officer · Feb 13, 2017 – May 15, 2018 · Past)
Chief Business Officer · Jun 24, 2015 – Sep 8, 2016 · Past
Andrea MatthewsChief Business Officer · Since at least Apr 17, 2023
Andrew KomjathyChief Commercial Officer · Since at least Sep 18, 2019
Deirdre A CunnaneChief Legal Officer · Feb 11, 2016 – Feb 13, 2019 · Past
Edward K HibbenChief Business Officer · Feb 8, 2018 – Feb 8, 2018 · Past
Ian C SandersonChief Financial Officer · Feb 11, 2016 – Feb 11, 2016 · Past
Michael JirousekChief Scientific Officer · Jun 24, 2015 – Jun 30, 2015 · Past
Noah ClauserChief Financial Officer · Since at least Dec 17, 2019
Ron LauferDirector · Jun 24, 2015 – Jun 30, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Astria Therapeutics Inc.